Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

U. Miami Climate Leader Sees Chance For Innovation No Photo Available

Nathan Hale

With Miami often called the "ground zero" of the climate change crisis, the University of Miami in 2022 launched a Climate Resilience ... (more story)

No Let-Up On DOJ Medicare Advantage Fraud Probes No Photo Available

Theresa Schliep

Federal scrutiny of Medicare Advantage fraud is showing no signs of abating.

Sanford-Marshfield Tie-Up Portends More Cross-Market Deals No Photo Available

Yeji Jesse Lee

A merger between two Midwest health systems is evidence of hospitals' desire to strike deals with players in other markets, according ... (more story)